Cytokinetics (CYTK) announced the appointment of Robert Landry to its Board of Directors. Mr. Landry brings over three decades of financial and operational expertise in the pharmaceutical industry, most recently having served as the CFO at Regeneron Pharmaceuticals (REGN) for 11 years.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CYTK:
- Cytokinetics Appoints Robert E. Landry to Board
- Roblox downgraded, Pinterest upgraded: Wall Street’s top analyst calls
- Optimistic Buy Rating for Cytokinetics Driven by Aficamten’s Market Potential and Undervalued Shares
- Cytokinetics initiated with a Buy at Citi
- Camzyos news has negative readthroughs for Cytokinetics, says BofA
Questions or Comments about the article? Write to editor@tipranks.com